ES557436A0 - Un procedimiento para preparar nuevos derivados de imidazol - Google Patents

Un procedimiento para preparar nuevos derivados de imidazol

Info

Publication number
ES557436A0
ES557436A0 ES557436A ES557436A ES557436A0 ES 557436 A0 ES557436 A0 ES 557436A0 ES 557436 A ES557436 A ES 557436A ES 557436 A ES557436 A ES 557436A ES 557436 A0 ES557436 A0 ES 557436A0
Authority
ES
Spain
Prior art keywords
sup
procedure
preparing new
imidazol derivatives
sub
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES557436A
Other languages
English (en)
Other versions
ES8801636A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Publication of ES557436A0 publication Critical patent/ES557436A0/es
Publication of ES8801636A1 publication Critical patent/ES8801636A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/60—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
ES557436A 1985-01-16 1987-03-05 Un procedimiento para preparar nuevos derivados de imidazol Expired ES8801636A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP405585 1985-01-16

Publications (2)

Publication Number Publication Date
ES557436A0 true ES557436A0 (es) 1988-02-16
ES8801636A1 ES8801636A1 (es) 1988-02-16

Family

ID=11574190

Family Applications (2)

Application Number Title Priority Date Filing Date
ES550972A Expired ES8706125A1 (es) 1985-01-16 1986-01-16 Un procedimiento para preparar nuevos derivados de imidiazol.
ES557436A Expired ES8801636A1 (es) 1985-01-16 1987-03-05 Un procedimiento para preparar nuevos derivados de imidazol

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES550972A Expired ES8706125A1 (es) 1985-01-16 1986-01-16 Un procedimiento para preparar nuevos derivados de imidiazol.

Country Status (13)

Country Link
US (1) US4894385A (es)
EP (1) EP0188383B1 (es)
JP (1) JPH0625141B2 (es)
KR (1) KR930004674B1 (es)
AT (1) ATE104967T1 (es)
AU (1) AU582206B2 (es)
CA (1) CA1296009C (es)
DE (1) DE3689807T2 (es)
DK (1) DK20886A (es)
ES (2) ES8706125A1 (es)
FI (1) FI90866C (es)
NO (1) NO166445C (es)
ZA (1) ZA86286B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR960010343B1 (ko) * 1987-12-09 1996-07-30 에스에스 세이야꾸 가부시끼가이샤 이미다졸 유도체
US5308860A (en) * 1993-01-15 1994-05-03 Rohm And Haas Company Cyanosulfonylethyltriazoles
JP2002167378A (ja) * 2000-09-22 2002-06-11 Ss Pharmaceut Co Ltd イミダゾール誘導体又はその塩
JP2006347882A (ja) * 2003-09-02 2006-12-28 Ss Pharmaceut Co Ltd ベンジルアルコール誘導体又はその塩

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2860862D1 (en) * 1977-10-13 1981-10-29 Siegfried Ag Imidazolylethylene-oxyalkyloxy derivatives and their thio analogues, methods for their preparation and pharmaceutical compositions containing them
JPS5951943B2 (ja) * 1978-08-21 1984-12-17 キツセイ薬品工業株式会社 新規なイミダゾ−ル誘導体
DK471479A (da) * 1978-12-13 1980-06-14 Pfizer Fremgangsmaade til fremstilling af imidazolderivater og salte deraf
JPS56120670A (en) * 1980-02-27 1981-09-22 Teijin Ltd 1-substituted imidazole derivative and its preparation
GB8400254D0 (en) * 1984-01-06 1984-02-08 Searle & Co Substituted alklidene imidazoles

Also Published As

Publication number Publication date
ES550972A0 (es) 1987-06-01
JPS61267557A (ja) 1986-11-27
DE3689807D1 (de) 1994-06-01
DK20886D0 (da) 1986-01-16
EP0188383A3 (en) 1988-06-22
FI860210A (fi) 1986-07-17
NO860114L (no) 1986-07-17
DK20886A (da) 1986-07-17
ES8801636A1 (es) 1988-02-16
ATE104967T1 (de) 1994-05-15
DE3689807T2 (de) 1994-08-25
EP0188383B1 (en) 1994-04-27
KR930004674B1 (ko) 1993-06-03
JPH0625141B2 (ja) 1994-04-06
US4894385A (en) 1990-01-16
CA1296009C (en) 1992-02-18
EP0188383A2 (en) 1986-07-23
ES8706125A1 (es) 1987-06-01
AU5242586A (en) 1986-07-24
ZA86286B (en) 1986-09-24
FI90866C (fi) 1994-04-11
AU582206B2 (en) 1989-03-16
KR860005793A (ko) 1986-08-13
NO166445B (no) 1991-04-15
FI90866B (fi) 1993-12-31
FI860210A0 (fi) 1986-01-16
NO166445C (no) 1991-08-07

Similar Documents

Publication Publication Date Title
ES8506677A1 (es) Un procedimiento para la preparacion de nuevos derivados de 8-cloro71,5-benzotiazepina.
JO1351B1 (en) Chemical compounds
DE3477488D1 (en) Polymethoxybenzyl piperazine derivatives, processes for their preparation and pharmaceutical compositions containing said derivatives
ES8704153A1 (es) Un procedimiento para preparar derivados de pirimidina
ATE66476T1 (de) Thianaphthen-derivate, ihre herstellung und verwendung.
ES557436A0 (es) Un procedimiento para preparar nuevos derivados de imidazol
ATE39920T1 (de) Cyclopentylether, verfahren zu ihrer herstellung und ihre pharmazeutische anwendung.
EP0066909A3 (en) Imidazole derivatives, pharmaceutical compositions containing them and processes for their production
NZ216110A (en) 4-(z)-6-((2,4,5-cis -2-alkyl-4-(2-hydroxyphenyl)-1,3- dioxan-5-yl) hexenoic acid derivatives and pharmaceutical compositions
ES8305758A1 (es) "un procedimiento para la preparacion de 2-(1,4-benzodioxan-2-il-metil)-imidazolina".
ATE78032T1 (de) 2-pyridylessigsaeurederivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ES8602789A1 (es) Procedimiento para preparar derivados de 14-hidroxiimino- eburnano racemicos y opticamente activos
HUT50461A (en) Process for producing imidazole derivatives inhibiting dopamin-beta-hydroxylase and pharmaceutical compositions comprising such compounds
MY104048A (en) New allylaminoethylazoles.
JPS5636414A (en) Anticonvulsant agent containing omega-aminoalkoxystilbene or its acid addition salt as active constituent
JPS5547639A (en) Preparation of alkylanthraquinone

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19971001